CLSK Cleanspark | $13.45 +8.8% | 7/8/2026 | | Reiterated Rating | $19.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/8/2026 |
MGX Metagenomi | $1.32
| 7/7/2026 | | Initiated Coverage | $7.00 ➝ $5.00 | Buy | 00.00% | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 7/7/2026 |
IRD Opus Genetics | $3.56 -6.6% | 7/6/2026 | | Reiterated Rating | $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 7/6/2026 |
IBIO iBio | $1.44 -0.7% | 7/2/2026 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for Chardan Capital rating of iBio (NASDAQ:IBIO) on 7/2/2026 |
TENX Tenax Therapeutics | $15.56 -2.6% | 7/2/2026 | | Reiterated Rating | $27.00 | Buy | 00.00% | View details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 7/2/2026 |
EYPT Eyepoint Pharmaceuticals | $13.73 -3.9% | 7/1/2026 | | Boost Price Target | $29.00 ➝ $65.00 | Buy | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 7/1/2026 |
ARWR Arrowhead Pharmaceuticals | $71.91 -3.0% | 6/30/2026 | | Reiterated Rating | $90.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/30/2026 |
PRQR ProQR Therapeutics | $1.70
| 6/26/2026 | | Lower Price Target | $4.00 ➝ $3.00 | Buy | 00.00% | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 6/26/2026 |
OCUL Ocular Therapeutix | $9.70 -1.8% | 6/25/2026 | | Boost Price Target | $21.00 ➝ $23.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 6/25/2026 |
TENX Tenax Therapeutics | $15.56 -2.6% | 6/22/2026 | | Initiated Coverage | $27.00 | Buy | 00.00% | View details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 6/22/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
IRD Opus Genetics | $3.56 -6.6% | 6/18/2026 | | Boost Price Target | $11.00 ➝ $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 6/18/2026 |
IRD Opus Genetics | $3.56 -6.6% | 6/17/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 6/17/2026 |
SABS SAB Biotherapeutics | $3.60 -3.5% | 6/17/2026 | | Boost Price Target | $14.00 ➝ $16.00 | Buy | 00.00% | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 6/17/2026 |
COYA Coya Therapeutics | $4.87 +0.2% | 6/12/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 6/12/2026 |
PURR Hyperliquid Strategies | $7.36 +2.8% | 6/12/2026 | | Reiterated Rating | $9.75 | Buy | 00.00% | View details for Chardan Capital rating of Hyperliquid Strategies (NASDAQ:PURR) on 6/12/2026 |
ZOOZ ZOOZ Power | $5.11 +1.0% | 6/12/2026 | | Lower Price Target | $40.00 ➝ $10.00 | Buy | 00.00% | View details for Chardan Capital rating of ZOOZ Power (NASDAQ:ZOOZ) on 6/12/2026 |
CAMP CAMP4 Therapeutics | $4.45 -1.1% | 6/10/2026 | | Set Price Target | $6.50 | Buy | 00.00% | View details for Chardan Capital rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 6/10/2026 |
CAMP CAMP4 Therapeutics | $4.45 -1.1% | 6/10/2026 | | Initiated Coverage | $6.50 | Buy | 00.00% | View details for Chardan Capital rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 6/10/2026 |
PHMMF Pharma Mar | $86.09 -5.3% | 6/9/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Pharma Mar (OTCMKTS:PHMMF) on 6/9/2026 |
VFS VinFast Auto | $3.12 +1.6% | 6/9/2026 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 6/9/2026 |
CLSK Cleanspark | $13.45 +8.8% | 6/8/2026 | | Boost Price Target | $16.00 ➝ $19.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 6/8/2026 |
HYPD Hyperion DeFi | $2.96 -0.3% | 6/8/2026 | | Lower Price Target | $8.25 ➝ $7.30 | Buy | 00.00% | View details for Chardan Capital rating of Hyperion DeFi (NASDAQ:HYPD) on 6/8/2026 |
KEEL Keel Infrastructure | $4.49 +3.0% | 6/8/2026 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of Keel Infrastructure (NASDAQ:KEEL) on 6/8/2026 |
PVLA Palvella Therapeutics | $149.68 +2.5% | 5/21/2026 | | Reiterated Rating | $240.00 | Buy | 00.00% | View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 5/21/2026 |
PURR Hyperliquid Strategies | $7.36 +2.8% | 5/20/2026 | | Boost Price Target | $8.45 ➝ $9.75 | Buy | 00.00% | View details for Chardan Capital rating of Hyperliquid Strategies (NASDAQ:PURR) on 5/20/2026 |
ALMS Alumis | $27.28 -2.9% | 5/19/2026 | | Boost Price Target | $38.00 ➝ $40.00 | Buy | 00.00% | View details for Chardan Capital rating of Alumis (NASDAQ:ALMS) on 5/19/2026 |
IMRX Immuneering | $5.21 +1.0% | 5/19/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 5/19/2026 |
IMTX Immatics | $9.35 +1.3% | 5/19/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for Chardan Capital rating of Immatics (NASDAQ:IMTX) on 5/19/2026 |
SNTI Senti Biosciences | $0.97 +0.8% | 5/15/2026 | | Boost Price Target | $11.00 ➝ $12.00 | Buy | 00.00% | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 5/15/2026 |
KEEL Keel Infrastructure | $4.49 +3.0% | 5/11/2026 | | Reiterated Rating | $4.50 | Buy | 00.00% | View details for Chardan Capital rating of Keel Infrastructure (NASDAQ:KEEL) on 5/11/2026 |
KOD Kodiak Sciences | $43.26 +5.3% | 5/11/2026 | | Upgrade | $14.00 ➝ $61.00 | Neutral ➝ Buy | 00.00% | View details for Chardan Capital rating of Kodiak Sciences (NASDAQ:KOD) on 5/11/2026 |
LXEO Lexeo Therapeutics | $4.62 -0.4% | 5/11/2026 | | Reiterated Rating | $17.00 | Buy | 00.00% | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 5/11/2026 |
RCKT Rocket Pharmaceuticals | $3.64 -2.2% | 5/11/2026 | | Reiterated Rating | $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/11/2026 |
KDK Kodiak AI | $4.53 -2.8% | 5/8/2026 | | Lower Price Target | $22.00 ➝ $15.00 | Buy | 00.00% | View details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 5/8/2026 |
IOVA Iovance Biotherapeutics | $3.93 -2.7% | 5/7/2026 | | Lower Price Target | $16.00 ➝ $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 5/7/2026 |
CLYM Climb Bio | $13.24 +0.2% | 5/5/2026 | | Initiated Coverage | $22.00 | Buy | 00.00% | View details for Chardan Capital rating of Climb Bio (NASDAQ:CLYM) on 5/5/2026 |
EDIT Editas Medicine | $3.16
| 5/5/2026 | | Boost Price Target | $3.50 ➝ $4.00 | Buy | 00.00% | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 5/5/2026 |
GLXY Galaxy Digital | $24.22 +3.7% | 5/4/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Galaxy Digital (NASDAQ:GLXY) on 5/4/2026 |
KEEL Keel Infrastructure | $4.49 +3.0% | 5/4/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Keel Infrastructure (NASDAQ:KEEL) on 5/4/2026 |
RIOT Riot Platforms | $20.19
| 5/4/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Riot Platforms (NASDAQ:RIOT) on 5/4/2026 |
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely
You don't need a big account to trade options.
In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up.
This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now. |
QURE uniQure | $41.52 +1.0% | 4/30/2026 | | Boost Price Target | $31.00 ➝ $37.00 | Buy | 00.00% | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 4/30/2026 |
RIOT Riot Platforms | $20.19
| 4/27/2026 | | Initiated Coverage | $27.50 | Buy | 00.00% | View details for Chardan Capital rating of Riot Platforms (NASDAQ:RIOT) on 4/27/2026 |
GLXY Galaxy Digital | $24.22 +3.7% | 4/27/2026 | | Initiated Coverage | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Galaxy Digital (NASDAQ:GLXY) on 4/27/2026 |
KEEL Keel Infrastructure | $4.49 +3.0% | 4/27/2026 | | Initiated Coverage | $4.50 | Buy | 00.00% | View details for Chardan Capital rating of Keel Infrastructure (NASDAQ:KEEL) on 4/27/2026 |
NTLA Intellia Therapeutics | $13.30 +2.2% | 4/27/2026 | | Boost Price Target | $27.00 ➝ $30.00 | Buy | 00.00% | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 4/27/2026 |
VFS VinFast Auto | $3.12 +1.6% | 4/23/2026 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 4/23/2026 |
ANRO Alto Neuroscience | $27.80 -0.8% | 4/22/2026 | | Reiterated Rating | $30.00 | Buy | 00.00% | View details for Chardan Capital rating of Alto Neuroscience (NYSE:ANRO) on 4/22/2026 |
PASG Passage Bio | $4.44 -0.4% | 4/21/2026 | | Set Price Target | $21.00 ➝ $7.00 | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 4/21/2026 |
PASG Passage Bio | $4.44 -0.4% | 4/21/2026 | | Downgrade | $21.00 ➝ $7.00 | Buy ➝ Hold | 00.00% | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 4/21/2026 |
IOVA Iovance Biotherapeutics | $3.93 -2.7% | 4/10/2026 | | Reiterated Rating | $16.00 | Buy | 00.00% | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 4/10/2026 |
IBIO iBio | $1.44 -0.7% | 4/9/2026 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for Chardan Capital rating of iBio (NASDAQ:IBIO) on 4/9/2026 |
PRQR ProQR Therapeutics | $1.70
| 4/9/2026 | | Reiterated Rating | $4.00 | Buy | 00.00% | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 4/9/2026 |
CLSK Cleanspark | $13.45 +8.8% | 4/8/2026 | | Reiterated Rating | $16.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 4/8/2026 |
ANRO Alto Neuroscience | $27.80 -0.8% | 4/2/2026 | | Reiterated Rating | $30.00 | Buy | 00.00% | View details for Chardan Capital rating of Alto Neuroscience (NYSE:ANRO) on 4/2/2026 |
PVLA Palvella Therapeutics | $149.68 +2.5% | 3/31/2026 | | Boost Price Target | $210.00 ➝ $240.00 | Buy | 00.00% | View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 3/31/2026 |
ALMS Alumis | $27.28 -2.9% | 3/30/2026 | | Reiterated Rating | $38.00 | Buy | 00.00% | View details for Chardan Capital rating of Alumis (NASDAQ:ALMS) on 3/30/2026 |
MNPR Monopar Therapeutics | $99.79 -3.4% | 3/30/2026 | | Reiterated Rating | $100.00 | Buy | 00.00% | View details for Chardan Capital rating of Monopar Therapeutics (NASDAQ:MNPR) on 3/30/2026 |
SNTI Senti Biosciences | $0.97 +0.8% | 3/30/2026 | | Lower Price Target | $13.00 ➝ $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 3/30/2026 |
ZOOZ ZOOZ Power | $5.11 +1.0% | 3/30/2026 | | Reiterated Rating | $40.00 | Buy | 00.00% | View details for Chardan Capital rating of ZOOZ Power (NASDAQ:ZOOZ) on 3/30/2026 |
CGTX Cognition Therapeutics | $1.01 -1.0% | 3/27/2026 | | Reiterated Rating | $4.00 | Buy | 00.00% | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/27/2026 |
MGTX MeiraGTx | $12.44 +0.8% | 3/27/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 3/27/2026 |
RCKT Rocket Pharmaceuticals | $3.64 -2.2% | 3/27/2026 | | Reiterated Rating | $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 3/27/2026 |
ALNY Alnylam Pharmaceuticals | $281.26 -2.4% | 3/25/2026 | | Reiterated Rating | $425.00 | Buy | 00.00% | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 3/25/2026 |
KDK Kodiak AI | $4.53 -2.8% | 3/25/2026 | | Reiterated Rating | $22.00 | Buy | 00.00% | View details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 3/25/2026 |
OCGN Ocugen | $1.43 +1.4% | 3/25/2026 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 3/25/2026 |
ZURA Zura Bio | $5.06 -1.7% | 3/23/2026 | | Boost Price Target | $10.00 ➝ $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 3/23/2026 |
ALMS Alumis | $27.28 -2.9% | 3/20/2026 | | Boost Price Target | $37.00 ➝ $38.00 | Buy | 00.00% | View details for Chardan Capital rating of Alumis (NASDAQ:ALMS) on 3/20/2026 |
ANNX Annexon | $5.55 -1.4% | 3/20/2026 | | Reiterated Rating | $16.00 | Buy | 00.00% | View details for Chardan Capital rating of Annexon (NASDAQ:ANNX) on 3/20/2026 |
SLDB Solid Biosciences | $9.63 -0.9% | 3/20/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 3/20/2026 |
FDMT 4D Molecular Therapeutics | $11.70 +3.5% | 3/19/2026 | | Reiterated Rating | $26.00 | Buy | 00.00% | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 3/19/2026 |
TSHA Taysha Gene Therapies | $5.70 +5.9% | 3/19/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/19/2026 |
CRVO CervoMed | $3.08 -6.9% | 3/18/2026 | | Boost Price Target | $15.00 ➝ $21.00 | Buy | 00.00% | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 3/18/2026 |
IBIO iBio | $1.44 -0.7% | 3/18/2026 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for Chardan Capital rating of iBio (NASDAQ:IBIO) on 3/18/2026 |
STOK Stoke Therapeutics | $29.13 -1.1% | 3/18/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 3/18/2026 |
ANRO Alto Neuroscience | $27.80 -0.8% | 3/17/2026 | | Reiterated Rating | $30.00 | Buy | 00.00% | View details for Chardan Capital rating of Alto Neuroscience (NYSE:ANRO) on 3/17/2026 |
ULYX Urgent.ly | $5.50
| 3/17/2026 | | Downgrade | $15.00 ➝ $5.50 | Buy ➝ Hold | 00.00% | View details for Chardan Capital rating of Urgent.ly (OTCMKTS:ULYX) on 3/17/2026 |
VFS VinFast Auto | $3.12 +1.6% | 3/17/2026 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 3/17/2026 |
COYA Coya Therapeutics | $4.87 +0.2% | 3/16/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/16/2026 |
PVLA Palvella Therapeutics | $149.68 +2.5% | 3/16/2026 | | Reiterated Rating | $210.00 | Buy | 00.00% | View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 3/16/2026 |
IRD Opus Genetics | $3.56 -6.6% | 3/12/2026 | | Boost Price Target | $9.00 ➝ $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 3/12/2026 |
OBIO Orchestra BioMed | $3.69 -3.4% | 3/12/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 3/12/2026 |
SLDB Solid Biosciences | $9.63 -0.9% | 3/12/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 3/12/2026 |
TNYA Tenaya Therapeutics | $0.86 +3.4% | 3/12/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/12/2026 |
KDK Kodiak AI | $4.53 -2.8% | 3/11/2026 | | Reiterated Rating | $22.00 | Buy | 00.00% | View details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 3/11/2026 |
SABS SAB Biotherapeutics | $3.60 -3.5% | 3/11/2026 | | Boost Price Target | $12.00 ➝ $14.00 | Buy | 00.00% | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 3/11/2026 |
DYN Dyne Therapeutics | $23.78 +0.6% | 3/9/2026 | | Reiterated Rating | $38.00 | Buy | 00.00% | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/9/2026 |
EDIT Editas Medicine | $3.16
| 3/9/2026 | | Reiterated Rating | $3.50 | Buy | 00.00% | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 3/9/2026 |
QURE uniQure | $41.52 +1.0% | 3/9/2026 | | Boost Price Target | $16.00 ➝ $31.00 | Buy | 00.00% | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 3/9/2026 |
CRVO CervoMed | $3.08 -6.9% | 3/5/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 3/5/2026 |
OCGN Ocugen | $1.43 +1.4% | 3/5/2026 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 3/5/2026 |
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad) Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states.
The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. See which companies control the supply chain behind this emerging tech |
EYPT Eyepoint Pharmaceuticals | $13.73 -3.9% | 3/4/2026 | | Boost Price Target | $27.00 ➝ $29.00 | Buy | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 3/4/2026 |
QURE uniQure | $41.52 +1.0% | 3/3/2026 | | Lower Price Target | $53.00 ➝ $16.00 | Buy | 00.00% | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 3/3/2026 |
VFS VinFast Auto | $3.12 +1.6% | 3/3/2026 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 3/3/2026 |
DYN Dyne Therapeutics | $23.78 +0.6% | 3/2/2026 | | Reiterated Rating | $38.00 | Buy | 00.00% | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/2/2026 |
NTLA Intellia Therapeutics | $13.30 +2.2% | 2/27/2026 | | Reiterated Rating | $26.00 | Buy | 00.00% | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 2/27/2026 |
IOVA Iovance Biotherapeutics | $3.93 -2.7% | 2/25/2026 | | Lower Price Target | $17.00 ➝ $16.00 | Buy | 00.00% | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 2/25/2026 |
PVLA Palvella Therapeutics | $149.68 +2.5% | 2/24/2026 | | Boost Price Target | $174.00 ➝ $210.00 | Buy | 00.00% | View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 2/24/2026 |
KDK Kodiak AI | $4.53 -2.8% | 2/19/2026 | | Reiterated Rating | $22.00 | Buy | 00.00% | View details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 2/19/2026 |
KRYS Krystal Biotech | $339.43 -6.6% | 2/18/2026 | | Boost Price Target | $220.00 ➝ $323.00 | Buy | 00.00% | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 2/18/2026 |
OCUL Ocular Therapeutix | $9.70 -1.8% | 2/18/2026 | | Reiterated Rating | $21.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 2/18/2026 |